NL7803973A - Peptidecomplexen uit desoxyribonucleinezuur bevattende organismen, alsmede geneesmiddel waarin een dergelijk complex als werkzaam bestanddeel aanwezig is. - Google Patents

Peptidecomplexen uit desoxyribonucleinezuur bevattende organismen, alsmede geneesmiddel waarin een dergelijk complex als werkzaam bestanddeel aanwezig is.

Info

Publication number
NL7803973A
NL7803973A NL7803973A NL7803973A NL7803973A NL 7803973 A NL7803973 A NL 7803973A NL 7803973 A NL7803973 A NL 7803973A NL 7803973 A NL7803973 A NL 7803973A NL 7803973 A NL7803973 A NL 7803973A
Authority
NL
Netherlands
Prior art keywords
peptid
complex
active substance
product including
medicinal product
Prior art date
Application number
NL7803973A
Other languages
English (en)
Original Assignee
R & Z Vermoegensverw Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19772717476 external-priority patent/DE2717476A1/de
Priority claimed from DE19772717475 external-priority patent/DE2717475A1/de
Priority claimed from DE19772749554 external-priority patent/DE2749554A1/de
Application filed by R & Z Vermoegensverw Gmbh filed Critical R & Z Vermoegensverw Gmbh
Publication of NL7803973A publication Critical patent/NL7803973A/nl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6025—Nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/622—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier non-covalent binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/821—Separation of nucleic acid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/822—Protozoa
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/823—Lower fungi, e.g. mold
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/823—Lower fungi, e.g. mold
    • Y10S530/824—Yeasts
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NL7803973A 1977-04-20 1978-04-14 Peptidecomplexen uit desoxyribonucleinezuur bevattende organismen, alsmede geneesmiddel waarin een dergelijk complex als werkzaam bestanddeel aanwezig is. NL7803973A (nl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19772717476 DE2717476A1 (de) 1977-04-20 1977-04-20 Peptidkomplex mit fuer mycobacterium tuberculosis und mycobacterium leprae spezifischen antigendeterminanten, zur diagnostischen, prophylaktischen und therapeutischen anwendung
DE19772717475 DE2717475A1 (de) 1977-04-20 1977-04-20 Peptidkomplex mit resistenzsteigernder wirkung gegen eine infektion mit bordetella pertussis keimen, seine verwendung zu impfstoffzubereitungen und diagnostischen zwecken
DE19772749554 DE2749554A1 (de) 1977-11-05 1977-11-05 Peptidkomplexe aus desoxyribonucleinsaeurehaltigen organismen mit jeweils spezifischen antigendeterminanten fuer den organismus, aus dem sie gewonnen werden, zur diagnostischen, prophylaktischen und therapeutischen anwendung

Publications (1)

Publication Number Publication Date
NL7803973A true NL7803973A (nl) 1978-10-24

Family

ID=27187175

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7803973A NL7803973A (nl) 1977-04-20 1978-04-14 Peptidecomplexen uit desoxyribonucleinezuur bevattende organismen, alsmede geneesmiddel waarin een dergelijk complex als werkzaam bestanddeel aanwezig is.

Country Status (17)

Country Link
US (1) US4228068A (nl)
JP (1) JPS5417108A (nl)
AT (1) AT374928B (nl)
CA (1) CA1128860A (nl)
CH (1) CH639667A5 (nl)
DK (1) DK168078A (nl)
EG (1) EG14174A (nl)
ES (1) ES468918A1 (nl)
FI (1) FI781194A (nl)
FR (1) FR2387991A1 (nl)
GB (1) GB1603189A (nl)
IE (1) IE46618B1 (nl)
IT (1) IT1112622B (nl)
NL (1) NL7803973A (nl)
NO (1) NO151153C (nl)
PT (1) PT67916B (nl)
SE (1) SE7804098L (nl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8402861L (sv) * 1984-05-28 1985-11-29 Stefan Svenson Rening av biologiskt material
US5013720A (en) * 1986-05-06 1991-05-07 Abbott Laboratories SAP-6-Val proteins and methods
JPH01501282A (ja) * 1986-12-08 1989-05-11 ホイツトセツト，ジエフリー　エイ． 肺胞疎水性界面活性物質関連タンパク質
US5371112A (en) * 1992-01-23 1994-12-06 The Sherwin-Williams Company Aqueous coating compositions from polyethylene terephthalate
MD3942C2 (ro) * 2009-01-22 2010-02-28 Институт Химии Академии Наук Молдовы Complecşi ai fierului şi cobaltului cu acidul furan-2-carboxilic cu proprietăţi antituberculoase
CN103351352B (zh) * 2013-07-15 2015-10-21 南通市华峰化工有限责任公司 一种5-苯基四氮唑新合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2741653A (en) * 1954-03-19 1956-04-10 Univ California Method of isolating nucleoproteins
US3862109A (en) * 1968-10-12 1975-01-21 Hitachi Ltd Method for obtaining a protein isolate from hydrocarbon assimilating microbial cells
US4007088A (en) * 1972-06-14 1977-02-08 Ceskoslovenska Akademie Ved Process of manufacturing native microbial protein with a low content of nucleic acids
SU473720A1 (ru) * 1972-09-15 1975-06-14 Институт Биологически Активных Веществ Дальневосточного Научного Центра Способ совместного получени протамин-сульфата и дезоксирибонуклеиновой кислоты
US3887431A (en) * 1972-11-29 1975-06-03 Anheuser Busch Yeast protein isolate with reduced nucleic acid content and process of making same
SE7401668L (nl) * 1974-02-07 1975-08-08 Scp Exploatering Ab
US3991215A (en) * 1974-02-11 1976-11-09 Anheuser-Busch, Incorporated Manufacture of yeast protein isolate having a reduced nucleic acid content by a thermal process

Also Published As

Publication number Publication date
PT67916B (de) 1979-11-14
DK168078A (da) 1978-10-21
IT1112622B (it) 1986-01-20
GB1603189A (en) 1981-11-18
NO781360L (no) 1978-10-23
FI781194A (fi) 1978-10-21
IE46618B1 (en) 1983-08-10
US4228068A (en) 1980-10-14
IE780767L (en) 1978-10-20
CA1128860A (en) 1982-08-03
PT67916A (de) 1978-05-01
FR2387991A1 (fr) 1978-11-17
EG14174A (en) 1983-03-31
CH639667A5 (de) 1983-11-30
SE7804098L (sv) 1978-10-21
NO151153C (no) 1985-02-20
IT7822501A0 (it) 1978-04-20
NO151153B (no) 1984-11-12
JPS5417108A (en) 1979-02-08
ATA260878A (de) 1983-10-15
ES468918A1 (es) 1979-08-16
AT374928B (de) 1984-06-12
FR2387991B1 (nl) 1982-07-23

Similar Documents

Publication Publication Date Title
NL190664C (nl) Gesubstitueerde benzhydrylpiperidinoderivaten met therapeutische werking en farmaceutische preparaten die deze verbindingen bevatten.
NL190580C (nl) Gesubstitueerde benzhydrylpiperidinederivaten met therapeutische werking en preparaten die deze stoffen bevatten.
ZA761118B (en) 1,4-dihydropyridine-carboxylic acid aralkyl esters,processes for their preparations and their use as medicaments
NL7708741A (nl) Werkwijze ter bereiding van prostaanzuurderiva- ten alsmede farmaceutische preparaten die deze derivaten als actieve component bevatten.
NL177749C (nl) N-(fenoxyalkyl)imidazolen en farmaceutische preparaten die deze verbindingen als werkzame stof bevatten.
NL7803195A (nl) Heterocyclische verbindingen met farmaceutische activiteit, werkwijzen ter bereiding daarvan, alsmede farmaceutische preparaten, die deze verbindingen als actieve component bevatten.
NL192265B (nl) Penemcarbonzuur-verbindingen en farmaceutische preparaten die deze verbindingen bevatten.
AU513890B2 (en) Water-insoluble biologically active compounds
NL7804725A (nl) 4-aminomethyl-1-(3,3,3-triarypropyl)-4arylpiperidinen en derivaten daarvan, alsmede geneesmiddelen met anti- -diarrhee activiteit, die deze verbindingen als actieve component bevatten.
FR2352808A1 (fr) Acides 12-azaprostanoiques utiles comme medicaments
NL930101I2 (nl) Gebruik van 3,3'-azo-bis-(6-hydroxybenzoëzuur) alseen medicijn en farmaceutische preparaten die dez e stof bevatten.
NL188645C (nl) 1-azaxanthon-3-carbonzuurverbindingen en farmaceutische preparaten die deze verbindingen bevatten.
LU77557A1 (fr) Nouveau 2-deoxystreptamine-aminoglycoside,son procede de preparation et medicament le contenant
NL7803973A (nl) Peptidecomplexen uit desoxyribonucleinezuur bevattende organismen, alsmede geneesmiddel waarin een dergelijk complex als werkzaam bestanddeel aanwezig is.
JPS51128414A (en) Medicine consisting of biological active polypeptide
BE866116A (nl) Peptidecomplexen uit desoxyribonucleinezuur bevattende organismen, alsmede geneesmiddel waarin een dergelijk complex als werkzaam bestanddeel aanwezig is.
JPS5377073A (en) Piperadine derivative compound and its production and medical drugs containing said compound
BE853557A (fr) Medicaments, cosmetiques et pesticides renfermant des fluoroacylresorcines.
NL7810758A (nl) Gesubstitueerde 7 beta-amidino-delta3-cefem-4-carbon- zuren alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL7904311A (nl) Hydantoinederivaten alsmede deze derivaten als actieve component bevattende farmaceutische preparaten.
NL7704084A (nl) Medicinale preparaten.
NL184896C (nl) Pyranochinolinonderivaten en gevormde farmaceutische preparaten die deze bevatten.
ZA764101B (en) Novel thionobenzene-phosphonic acid o,o-diesters and their use as insecticides and acaricides
NL177018C (nl) Fenylpropionzuurderivaten, alsmede dergelijke derivaten bevattende farmaceutische preparaten.
NL7808897A (nl) 15-deoxy-16-hydroxy-16-gesubstitueerde prostaanzuren, alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: WILHELM. GUENTHER -

BV The patent application has lapsed